Who owns Lineage Cell Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LCTX from SEC Form 13F filings across 130 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 130 institutions disclosed 111.3M shares of Lineage Cell Therapeutics, Inc. worth $145.8M — about 44.6% of shares outstanding; the largest disclosed holder is BROADWOOD CAPITAL INC. Source: SEC Form 13F filings, parsed by EvidInvest.
130
13F holders
$145.8M
value, 2026 filers
44.6%
of shares outstanding (111.3M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LCTX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BROADWOOD CAPITAL INC | 49.6M | $64.9M | 3.4% | 19.9% | 0.0% |
| 2 | BlackRock, Inc. | 13.2M | $17.3M | 0.0% | 5.3% | +241.2% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 9.1M | $11.9M | 0.0% | 3.6% | +8.9% |
| 4 | Defender Capital, LLC. | 6.6M | $8.6M | 2.8% | 2.6% | -1.9% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 5.3M | $6.9M | 0.0% | 2.1% | +110.0% |
| 6 | FIFTH THIRD BANCORP | 4.6M | $6.0M | 0.0% | 1.8% | 0.0% |
| 7 | MILLENNIUM MANAGEMENT LLC | 3.0M | $4.0M | 0.0% | 1.2% | -45.7% |
| 8 | STATE STREET CORP | 2.3M | $3.0M | 0.0% | 0.9% | +112.3% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 1.7M | $2.2M | 0.0% | 0.7% | +26.0% |
| 10 | NORTHERN TRUST CORP | 1.7M | $2.2M | 0.0% | 0.7% | +231.9% |
| 11 | MORGAN STANLEY | 1.5M | $1.9M | 0.0% | 0.6% | -21.2% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 1.3M | $1.8M | 0.0% | 0.5% | -36.7% |
| 13 | MARSHALL WACE, LLP | 1.3M | $1.7M | 0.0% | 0.5% | -58.2% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 1.3M | $1.7M | 0.0% | 0.5% | new |
| 15 | UBS Group AG | 687,051 | $900,036 | 0.0% | 0.3% | -49.9% |
| 16 | RED CRANE WEALTH MANAGEMENT, LLC | 597,263 | $782,415 | 0.6% | 0.2% | 0.0% |
| 17 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 577,435 | $756,440 | 0.0% | 0.2% | +344.4% |
| 18 | BARCLAYS PLC | 508,668 | $666,354 | 0.0% | 0.2% | +29.3% |
| 19 | Squarepoint Ops LLC | 444,774 | $582,654 | 0.0% | 0.2% | +210.6% |
| 20 | GOLDMAN SACHS GROUP INC | 433,266 | $567,578 | 0.0% | 0.2% | -63.0% |
| 21 | CITADEL ADVISORS LLC | 426,169 | $558,282 | 0.0% | 0.2% | +225.4% |
| 22 | BANK OF AMERICA CORP /DE/ | 424,373 | $555,928 | 0.0% | 0.2% | +1.2% |
| 23 | Bank of New York Mellon Corp | 391,675 | $513,094 | 0.0% | 0.2% | +1587.3% |
| 24 | FLPUTNAM INVESTMENT MANAGEMENT CONEW | 304,562 | $398,976 | 0.0% | 0.1% | new |
| 25 | Nuveen, LLCNEW | 245,384 | $321,453 | 0.0% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.